BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10137062)

  • 1. Educational effort and CQI program improves ordering of serum digoxin levels.
    Wade WE; McCall CY
    Hosp Formul; 1994 Sep; 29(9):657-9. PubMed ID: 10137062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How a CQI program improved aminoglycoside use in a community hospital.
    Wade WE; McCall CY
    Hosp Formul; 1995 Feb; 30(2):114-6. PubMed ID: 10140350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a therapeutic drug monitoring program for digoxin.
    Wing D; Duff HJ
    Arch Intern Med; 1987 Aug; 147(8):1405-8. PubMed ID: 3632149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clinical pharmacy services on appropriateness of serum digoxin concentration monitoring.
    Klamerus KJ; Munger MA
    Am J Hosp Pharm; 1988 Sep; 45(9):1887-93. PubMed ID: 3228120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assuring the quality of a clinical pharmacokinetics service.
    Waller DJ; Smith SR
    Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target drug monitoring: a cost-effective service provided by staff pharmacists.
    Chrymko MM; Meyer JD; Kelly WN
    Hosp Pharm; 1994 Apr; 29(4):347, 350-2. PubMed ID: 10133463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring: improved performance through educational intervention.
    D'Angio RG; Stevenson JG; Lively BT; Morgan JE
    Ther Drug Monit; 1990 Mar; 12(2):173-81. PubMed ID: 2315974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA; Chow MS; Jay GT; Quintiliani R
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The history of a comprehensive pharmacokinetic service.
    McLean W; Lalonde R; Roy M
    Can J Hosp Pharm; 1989 Dec; 42(6):223-8. PubMed ID: 10304198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a computerized digoxin pharmacokinetic consultation service.
    Rich DS; Mahoney CD; Jeffrey LP; Pezzullo JC
    Hosp Pharm; 1981 Jan; 16(1):23-7. PubMed ID: 10249750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral communication on intravenous wastage: talk is cheap.
    Boomer G; Savoy LB; Marten R
    Hosp Pharm; 1993 May; 28(5):404-5, 407-9. PubMed ID: 10126024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an education program on cefazolin prescribing.
    Blain L; O'Brodovich M
    Can J Hosp Pharm; 1989 Apr; 42(2):69-71. PubMed ID: 10292923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of data collection method on results of serum digoxin concentration audit.
    Makela EH; Davis SK; Piveral K; Miller WA; Pleasants RA; Gadsden RH; Leman RB
    Am J Hosp Pharm; 1988 Jan; 45(1):126-30. PubMed ID: 3348225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of a continuous quality improvement program in a tertiary-care medical center.
    Stern Z; Rotem O; Wolfenson M; Gedalia N; Adato-Levy R; Mor-Yosef S
    Clin Perform Qual Health Care; 1996; 4(3):131-6. PubMed ID: 10159301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance program for a nuclear pharmacy.
    Hiltz A; Pierce S
    Can J Hosp Pharm; 1991 Feb; 44(1):25-9. PubMed ID: 10110040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven years of experience with a pharmacokinetic service.
    Job ML; Ward ES; Murphy JE
    Hosp Pharm; 1989 Jul; 24(7):512-9, 526. PubMed ID: 10318293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to tie a drug therapy improvement program to physician credentialing.
    Tse CS; Roecker W; Benitez M; Musabji M
    Hosp Formul; 1994 Sep; 29(9):646-50, 656. PubMed ID: 10137061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.